OptraSCAN receives US FDA 510(k) clearance for digital pathology system Clearance covers integrated pathology system for HER2 assessment in clinical practice
Molbio Diagnostics invests $30 million in OptraSCAN for digital pathology expansion Partnership aims to expand AI-driven diagnostic solutions globally and improve healthcare access in underserved regions
Neuberg Diagnostics and OptraSCAN announce JV Launch Neuberg DIGIPATH, Powered by OptraSCAN in UAE, India and South Africa to provide advanced and affordable digital pathology…
Budget expectations 2019 Health industry experts urge the government on healthcare spending and ensure increased access
